Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Investment Corporation (CIC) is a state-owned investment fund that manages a portion of China's foreign exchange reserves. It invests globally across various asset classes including public equities, fixed income, alternative assets (private equity, real estate, infrastructure) and also focuses on strategic investments. As of 2023-2025, it manages over $1.33 trillion in assets under management (AUM). While it invests in various sectors including technology and natural resources, and has made investments in health-related firms, it is fundamentally a financial investor and not a life science/biotech/pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Investment Wealth Venture Fund.